8-K: Selectis Health Secures $750,000 Line of Credit with Southern Bank

Selectis Health, Inc. has entered into a Commercial Line of Credit Agreement with Southern Bank for a $750,000 line of credit at a fixed interest rate of 8.50% per annum.

Summary

• Selectis Health, Inc. has secured a $750,000 line of credit from Southern Bank.
• The credit line has a fixed interest rate of 8.50% per annum.
• The maturity date for the line of credit is April 12, 2025.

Sentiment

Score: 7

Explanation: The announcement is positive as it secures funding, but it also introduces debt obligations. The sentiment is neutral to slightly positive.

Positives

• The new line of credit provides Selectis Health with additional financial flexibility.
• The fixed interest rate of 8.50% provides predictability in borrowing costs.

Risks

• The company will be required to repay the $750,000 principal amount by April 12, 2025.
• The company will be required to pay interest at 8.50% per annum on any drawn funds.

Management Comments

• Adam Desmond, CEO, signed the report on behalf of Selectis Health, Inc.

Industry Context

This type of financing is common for companies seeking to fund operations or growth initiatives.

Comparison to Industry Standards

• A line of credit at 8.50% is within the typical range for small to medium sized businesses, but the specific rate would depend on the creditworthiness of Selectis Health and the prevailing market conditions.
• Comparable companies would likely have similar credit facilities with interest rates varying based on their financial health and the lender's risk assessment.

Stakeholder Impact

• Shareholders may view the line of credit as a positive step for the company's financial stability.
• Creditors now have a new financial obligation to consider.

Key Dates

Keywords

line of credit, financing, debt, loan, Southern Bank, Selectis Health